Phase 2a Study of 0.05% Difluprednate Ophthalmic Emulsion in the Treatment of Postoperative Inflammation After Cataract Surgery
Latest Information Update: 24 Dec 2014
At a glance
- Drugs Difluprednate (Primary)
- Indications Postoperative inflammation
- Focus Therapeutic Use
- Sponsors Sirion Therapeutics
Most Recent Events
- 24 Dec 2014 New trial record